Showing results (331-340 of 380) with videos related to
Sort By:
Pageof 38
The Journal of Trauma and Acute Care Surgery|April 26, 2021
Staying on target: Maintaining a balanced resuscitation during damage-control resuscitation improves survivalAllyson M Hynes, Zhi Geng, Daniela Schmulevich, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2021
A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinomaEddy S Yang, Eric Deutsch, Altan Mehmet, et al.Journal of General Internal Medicine|May 18, 2019
Incorporating Theory into Practice: Reconceptualizing Exemplary Care Coordination Initiatives from the US Veterans Health Delivery SystemKathryn M McDonald, Sara J Singer, Sherri Sheinfeld Gorin, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancerThomas Wehler, Michael Thomas, Christian Schumann, et al.BMJ (Clinical Research Ed.)|May 23, 2023
Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort studyAmy Sb Bohnert, Kyle Kumbier, Mazhgan Rowneki, et al.Investigational New Drugs|June 20, 2014
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancerEmiliano Calvo, Victor J Chen, Mark Marshall, et al.Plos Medicine|October 21, 2021
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort studyGeorge N Ioannou, Jacqueline M Ferguson, Ann M O'Hare, et al.JAMA Network Open|November 11, 2022
Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022Kristina L Bajema, Xiao Qing Wang, Denise M Hynes, et al.The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.Frontiers in Health Services|September 1, 2023
Understanding care coordination for Veterans with complex care needs: protocol of a multiple-methods study to build evidence for an effectiveness and implementation studyDenise M Hynes, Diana J Govier, Meike Niederhausen, et al.Pageof 38